145 related articles for article (PubMed ID: 12070716)
1. Is the presence of interleukin-2 receptor alpha in the serum of colorectal liver metastases patients derived from hepatic natural killer cells?
Vermijlen D; Luo D; Kruhøffer M; ØRntoft TF; Kuppen PJ; Wisse E
Cancer Immunol Immunother; 2002 Jul; 51(5):291-2. PubMed ID: 12070716
[No Abstract] [Full Text] [Related]
2. Decrease in intrahepatic CD56+ lymphocytes in gastric and colorectal cancer patients with liver metastases.
Gulubova M; Manolova I; Kyurkchiev D; Julianov A; Altunkova I
APMIS; 2009 Dec; 117(12):870-9. PubMed ID: 20078551
[TBL] [Abstract][Full Text] [Related]
3. Natural killer cell depletion confounds the antitumor mechanism of endogenous IL-12 overexpression.
Miller G; Bleier JI; Antonescu C; Pillarisetty VG; Shah AB; Lahrs S; DeMatteo RP
Int J Cancer; 2004 Jun; 110(3):395-402. PubMed ID: 15095305
[TBL] [Abstract][Full Text] [Related]
4. T cells but not NK cells are associated with a favourable outcome for resected colorectal liver metastases.
Pugh SA; Harrison RJ; Primrose JN; Khakoo SI
BMC Cancer; 2014 Mar; 14():180. PubMed ID: 24625075
[TBL] [Abstract][Full Text] [Related]
5. The Nlrp3 Inflammasome Suppresses Colorectal Cancer Metastatic Growth in the Liver by Promoting Natural Killer Cell Tumoricidal Activity.
Dupaul-Chicoine J; Arabzadeh A; Dagenais M; Douglas T; Champagne C; Morizot A; Rodrigue-Gervais IG; Breton V; Colpitts SL; Beauchemin N; Saleh M
Immunity; 2015 Oct; 43(4):751-63. PubMed ID: 26384545
[TBL] [Abstract][Full Text] [Related]
6. Repeat hepatic surgery for colorectal cancer metastasis to the liver.
Pinson CW; Wright JK; Chapman WC; Garrard CL; Blair TK; Sawyers JL
Ann Surg; 1996 Jun; 223(6):765-73; discussion 773-6. PubMed ID: 8645050
[TBL] [Abstract][Full Text] [Related]
7. The association between preoperative serum CEA concentrations and synchronous liver metastasis in colorectal cancer patients.
Pakdel A; Malekzadeh M; Naghibalhossaini F
Cancer Biomark; 2016; 16(2):245-52. PubMed ID: 26756614
[TBL] [Abstract][Full Text] [Related]
8. Perioperative change in peripheral blood monocyte count may predict prognosis in patients with colorectal liver metastasis after hepatic resection.
Haruki K; Shiba H; Fujiwara Y; Furukawa K; Wakiyama S; Ogawa M; Ishida Y; Misawa T; Yanaga K
J Surg Oncol; 2012 Jul; 106(1):31-5. PubMed ID: 22231029
[TBL] [Abstract][Full Text] [Related]
9. Longterm effects of hepatic arterial interleukin-2-based immunochemotherapy after potentially curative resection of colorectal liver metastases.
Okuno K; Yasutomi M; Hida J; Kayama H; Nakai T; Funai S; Koh K
J Am Coll Surg; 1998 Sep; 187(3):271-5. PubMed ID: 9740184
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy for hepatic micrometastasis of murine colon carcinoma.
Shiratori Y; Kanai F; Hikiba Y; Moriyama H; Hamada H; Matsumura M; Tanaka T; Lan KH; Ohashi M; Okano K; Naito M; Omata M
J Hepatol; 1998 May; 28(5):886-95. PubMed ID: 9625325
[TBL] [Abstract][Full Text] [Related]
11. Enhanced activity of CMP-neuAc:Gal beta 1-4GlcNAc:alpha 2,6-sialyltransferase in metastasizing human colorectal tumor tissue and serum of tumor patients.
Gessner P; Riedl S; Quentmaier A; Kemmner W
Cancer Lett; 1993 Dec; 75(3):143-9. PubMed ID: 8313349
[TBL] [Abstract][Full Text] [Related]
12. Serum carboxypeptidaseA4 levels predict liver metastasis in colorectal carcinoma.
Sun L; Guo C; Burnett J; Yang Z; Ran Y; Sun D
Oncotarget; 2016 Nov; 7(48):78688-78697. PubMed ID: 27780921
[TBL] [Abstract][Full Text] [Related]
13. Treatment of hepatic metastasis of the colon26 adenocarcinoma with an alpha-galactosylceramide, KRN7000.
Nakagawa R; Motoki K; Ueno H; Iijima R; Nakamura H; Kobayashi E; Shimosaka A; Koezuka Y
Cancer Res; 1998 Mar; 58(6):1202-7. PubMed ID: 9515806
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of immunological escape mechanisms in a mouse model of colorectal liver metastases.
Grimm M; Gasser M; Bueter M; Strehl J; Wang J; Nichiporuk E; Meyer D; Germer CT; Waaga-Gasser AM; Thalheimer A
BMC Cancer; 2010 Mar; 10():82. PubMed ID: 20205946
[TBL] [Abstract][Full Text] [Related]
15. [Role of hepatic arterial infusion chemotherapy in the treatment of colorectal cancer liver metastases].
Liu M; Xing BC
Zhonghua Yi Xue Za Zhi; 2013 Mar; 93(12):881-3. PubMed ID: 23863668
[No Abstract] [Full Text] [Related]
16. [Clinicopathological analysis of synchronous hepatic metastases from colorectal cancer].
Ye YJ; Wang S; Wu J; Shen ZL; Yin MJ; Yang XD; Jiang KW; Zhou J
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 May; 11(3):208-12. PubMed ID: 18478460
[TBL] [Abstract][Full Text] [Related]
17. Improving resectability of hepatic colorectal metastases: expert consensus statement by Abdalla et al.
Adams RB; Haller DG; Roh MS
Ann Surg Oncol; 2006 Oct; 13(10):1281-3. PubMed ID: 16964448
[No Abstract] [Full Text] [Related]
18. Overexpression of miR-17 is correlated with liver metastasis in colorectal cancer.
Lai H; Zhang J; Zuo H; Liu H; Xu J; Feng Y; Lin Y; Mo X
Medicine (Baltimore); 2020 Feb; 99(9):e19265. PubMed ID: 32118734
[TBL] [Abstract][Full Text] [Related]
19. Clinical correlation of high activity dynamic hepatic scintigraphy in patients with colorectal cancer.
Hemingway DM; Cooke TG; McCurrach G; Bessent RG; Carter R; McKillop JH; McArdle CS
Br J Cancer; 1992 May; 65(5):781-2. PubMed ID: 1586609
[TBL] [Abstract][Full Text] [Related]
20. Treatment of liver metastases from colorectal cancer.
Tol J; Punt CJ
Neth J Med; 2006 May; 64(5):133-5. PubMed ID: 16702610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
